ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,350.00
      -0.33%
      Dow Jones
      42,208.22
      0.20%
      Brent Oil
      74.115
      -0.60%
      Bitcoin
      63,532.78
      -1.15%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Heat Biologics Inc (HTBX) Quote

      Heat Biologics Inc

      Heat Biologics Inc (HTBX)

      NASDAQ
      2.83
      0.00
      (0.00%)
      Closed September 24 4:00PM
      Delayed by 15 minutes
      2.83
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      2.83
      Bid
      2.81
      Ask
      2.89
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      73.812M
      Previous Close
      2.83
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      26,082,000
      Dividend Yield
      -
      PE Ratio
      -0.43
      Earnings Per Share (EPS)
      -1.73
      Revenue
      7M
      Net Profit
      -45.22M

      About Heat Biologics Inc

      Heat Biologics Inc is an immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy and Comb... Heat Biologics Inc is an immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy and Combination Pan-Antigen Cytotoxic Therapy form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically modified, irradiated human cancer cells that secrete tumour-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      ir.scorpiusbiologics.com/
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      HTBX Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      21 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      21 hours ago

      Heat Biologics Announces Planned Transfer to the NYSE American

      DURHAM, N.C., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

      February 02 2022
      GlobeNewswire Inc.

      Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

      Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023 Reaffirms ANTHIM as an important medical countermeasure in the U.S...

      January 31 2022
      GlobeNewswire Inc.

      Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

      DURHAM, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

      January 12 2022
      GlobeNewswire Inc.

      Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

      DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

      December 21 2021
      GlobeNewswire Inc.

      Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

      Designed for rapid “plug and play” programming and stockpiling against emerging infectious agents and viral mutations Emergence of Omicron and other COVID-19 variants underscores the need for a...

      November 30 2021
      GlobeNewswire Inc.

      Heat Biologics Provides Third Quarter 2021 Business Update

      DURHAM, N.C., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), today provided strategic, financial, and operational updates for the third quarter ended September...

      November 10 2021
      GlobeNewswire Inc.

      Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy

      DURHAM, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to...

      October 06 2021
      GlobeNewswire Inc.

      Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

      DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the...

      September 15 2021
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MSGMMotorsport Games Inc
      $ 1.48
      (34.55%)
      		2.94M
      VSMEVS Media Holdings Ltd
      $ 1.61
      (30.89%)
      		2.49M
      ELYMEliem Therapeutics Inc
      $ 8.17
      (24.54%)
      		277.25k
      TOIOncology Institute Inc
      $ 0.349
      (20.10%)
      		1
      STSSSharps Technology Inc
      $ 0.2009
      (17.83%)
      		3.97k
      VTNRVertex Energy Inc
      $ 0.1598
      (-55.73%)
      		1.24M
      PLBYPLBY Group Inc
      $ 0.53
      (-26.40%)
      		74
      SFIXStitch Fix Inc
      $ 2.80
      (-25.33%)
      		28.54k
      PTIXProtagenic Therapeutics Inc
      $ 0.46
      (-23.46%)
      		15
      NRSNNeuroSense Therapeutics Ltd
      $ 1.01
      (-19.20%)
      		635
      ELABElevai Labs Inc
      $ 0.1102
      (6.99%)
      		5.09M
      MTCMMTec Inc
      $ 0.2813
      (-1.51%)
      		2.96M
      MSGMMotorsport Games Inc
      $ 1.48
      (34.55%)
      		2.94M
      VSMEVS Media Holdings Ltd
      $ 1.61
      (30.89%)
      		2.49M
      SQQQProShares UltraPro Short QQQ
      $ 7.58
      (-0.92%)
      		1.24M

      Discussion

      View Full Feed
      CarlCarlMcB CarlCarlMcB 2 minutes ago
      Reeling $$$$$ whale on $$$$$$$$
      AGRI
      TrendTrade2016 TrendTrade2016 3 minutes ago
      THE OTC DECIMATION IS ENTERING INTO THE FINAL PHASE OF THE BIGGEST OTC INSIDER SELLING PHASE ITS EVER SEEN AND THE NEXT 6 WEEKS IS GOING TO ROCK THE CLOWN CIRCUS LIKE WE HAVE NEVER SEEN
      Penny2Dime Penny2Dime 4 minutes ago
      Great!
      BDPT
      ITYS ITYS 5 minutes ago
      MWWC issues more conversion shares than it is authorized to, it breaches compliance with securities laws. --ouch

      If an OTC (Over-the-Counter) company issues more conversion shares than it is authorized to, it breaches compliance with securities laws. Here are some potential consequenc
      MWWC
      TrendTrade2016 TrendTrade2016 5 minutes ago
      WE ARE DAYS AWAY FROM THE BEGINNING OF THE MARKET CORRECTION AND ANYONE CALLING THE MARKET CONTINUATION IS A CLOWN
      Juntao Juntao 5 minutes ago
      $AUTR https://www.otcmarkets.com/stock/AUTR/security
      AUTR
      Money hunt Money hunt 7 minutes ago
      Take out the news
      FOXO
      Money hunt Money hunt 9 minutes ago
      We need news FOXO AI
      FOXO
      sctts sctts 10 minutes ago
      $$$ Today is the Day $$$$

      $$$$ $frx $$$$
      FRX
      floblu14 floblu14 10 minutes ago
      From my July 27, 2024 post -

      FWIW -

      It still is a big IF that ENTA wins summary judgment against PFIZER. Even a mediated settlement is quite positive.

      Back in June of 2022, RBC Capital Markets analyst Brian Abrahams states -

      "A typical roya
      ENTA
      eagle8 eagle8 11 minutes ago
      Thanks for this interesting post ATL.
      It would be something if the CI (with still very nasty side effects) could be replaced by vitamin C.

      GLTU
      NWBO
      ITYS ITYS 11 minutes ago
      Its pretty simple to read and understand. How you feel Williams is in middle makes no sense, your not even good at distorting the truth lol

      FACT CHECK,
      Coronacide filed lawsuit against Wellness Matrix

      CoronaCide Test Kits
      https://cases.justia.com/federal/d
      MGON
      prototype_101 prototype_101 12 minutes ago
      Jeunke said, The Polariton/ Lightwave announcement implies sampling/ scalable production on 200 mm wafers from AMF. Please realize that this can be sold to transceiver companies, but also directly to hyperscalers designing their own solutions like Facebook, Amazon, Google. It forces the complete sup
      LWLG
      TrendTrade2016 TrendTrade2016 14 minutes ago
      clowns and bagholders will be feeling lots of anxiety with this garbage as the weekly takes its hostages
      TGRP
      ITYS ITYS 17 minutes ago
      Yes, you can bid whack but i was referring to actually putting an ask out and getting it hit,
      They are selling around the others. Many of the bids/asks are all or none blocks.

      Conboy gets 10% royalty, so last Q they posted $108k for 3 months...YA think he is doing all that wor
      GEVI
      Omar8 Omar8 19 minutes ago
      AlwaysRed,






      There are still contracts and this month closing fast, will there be a push down ?


      https://www.cmegroup.com/markets/metals/precious/silver.volume.html
      SLV
      TrendTrade2016 TrendTrade2016 19 minutes ago
      getting close to destruction as the next tweet demolishes this scam
      BIEI
      chicks0123 chicks0123 20 minutes ago
      Good morning CLNVERS
      CLNV
      SkeBallLarry SkeBallLarry 22 minutes ago
      I'm living in big time fear these days. >

      Same here, K2 ... I don't like all I'm hearing " .. !!
      WojD40 WojD40 23 minutes ago
      From chatGPT on the subject of inspections. I think the Advent license was a major major hurdle.

      For MHRA (Medicines and Healthcare products Regulatory Agency) approval, there are several types of inspections that may be required, particularly for advanced therapies like the personali
      NWBO
      ksquared ksquared 26 minutes ago
      Good Morning back atcha, cap. I also read (skim) through the online comments.
      It's horrifying how many people jump in to vilify Trump. What the....???
      Mon Dieu. I'm living in big time fear these days.
      Stay safe.
      Money hunt Money hunt 28 minutes ago
      Going to the next level, accumulate all you can now, resistance will be tested
      RNAZ
      Nolis Nolis 28 minutes ago
      Time to cover
      LWLG
      TommyBoyTrader9460 TommyBoyTrader9460 30 minutes ago
      $ADHC
      https://x.com/autumnsdad1/status/1838875376778424501?s=61
      ADHC

      Your Recent History

      NASDAQ
      HTBX
      Heat Biologics
      Delayed Upgrade Clock